Announce Date | 07/30/2025 |
EPS Normalized Actual | $1.66 (Beat by $0.18) |
EPS GAAP Actual | $1.66 (Beat by $0.18) |
Revenue Actual | $2.605B |
Revenue Surprise | Beat by $2605M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2028 | 7.38832 | 13.96 | 5.90674 | 8.98511 | 3 |
Jun 2028 | 5.8 | 17.78 | 4.79152 | 6.94268 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | 0 | 2.605B | -44.49% | 2605M |
FQ1 2025 (Mar 2025) | 1.54 | 1.54 | 2.294B | -50.7% | 2294M |
FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 4.285B | 29.24% | 4285M |
FQ3 2024 (Sep 2024) | 1.4 | 1.4 | 4.095B | 32.84% | 4095M |
FQ2 2024 (Jun 2024) | 0.92 | 0.92 | 3.764B | 29.01% | 3764M |
FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 3.457B | 18.92% | 3457M |
FQ4 2023 (Dec 2023) | -0.87 | -0.87 | 3.032B | -2.47% | 3032M |
FQ3 2023 (Sep 2023) | -2.12 | -2.12 | 2.75B | -35.85% | 2750M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 1.55534 | -- | 1.52462 | 1.59789 | 5 |
FQ4 2027 (Dec 2027) | 0.94 | -- | 0.94 | 0.94 | 3 |
FQ3 2027 (Sep 2027) | 0.86 | -- | 0.86 | 0.86 | 4 |
FQ2 2027 (Jun 2027) | 2.24004 | -- | 2.21433 | 2.27543 | 9 |
FQ1 2027 (Mar 2027) | 2.17396 | -- | 2.149 | 2.20831 | 9 |
FQ4 2026 (Dec 2026) | 1.92567 | -- | 1.79277 | 2.04118 | 7 |
FQ3 2026 (Sep 2026) | 2.35462 | -- | 2.32759 | 2.39182 | 5 |
FQ2 2026 (Jun 2026) | 1.13293 | -- | 1.09292 | 1.19475 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 2.45B | -- | 2.42B | 2.5B | 6 |
FQ4 2027 (Dec 2027) | 2.18B | -- | 2.18B | 2.18B | 4 |
FQ3 2027 (Sep 2027) | 2.1B | -- | 2.1B | 2.1B | 5 |
FQ2 2027 (Jun 2027) | 4.65B | -- | 4.61B | 4.71B | 5 |
FQ1 2027 (Mar 2027) | 4.55B | -- | 4.51B | 4.6B | 10 |
FQ4 2026 (Dec 2026) | 4.56B | -- | 4.31B | 4.77B | 8 |
FQ3 2026 (Sep 2026) | 4.79B | -- | 4.75B | 4.85B | 5 |
FQ2 2026 (Jun 2026) | 4.2B | 38 | 4.09B | 4.38B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
FQ1 2025 (Mar 2025) | 1.54 | 1.54 | 100% | |
FQ4 2024 (Dec 2024) | 1.68 | 1.68 | 100% | |
FQ3 2024 (Sep 2024) | 1.4 | 1.4 | 100% | |
FQ2 2024 (Jun 2024) | 0.92 | 0.92 | 100% | |
FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 100% | |
FQ4 2023 (Dec 2023) | -0.87 | -0.87 | 100% | |
FQ3 2023 (Sep 2023) | -2.12 | -2.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $2.61B | $2605M | 100% |
FQ1 2025 (Mar 2025) | $0B | $2.29B | $2294M | 100% |
FQ4 2024 (Dec 2024) | $0B | $4.29B | $4285M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.1B | $4095M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.76B | $3764M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.46B | $3457M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.03B | $3032M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.75B | $2750M | 100% |